'Clinically meaningful' presentation slideshows

Clinical Significance for Quality of Life Endpoints in Clinical Trials

Jeff A. Sloan, Ph.D. Mayo Clinic, Rochester, MN, USA. Clinical Significance for Quality of Life Endpoints in Clinical Trials. FDA/Industry Statistics Workshop Washington, September 16, 2005. Primary goal: advance the state of the science to help cancer patient QOL soar.

496 views • 33 slides

Clinical Significance for Quality of Life Endpoints in Clinical Trials

Jeff A. Sloan, Ph.D. Mayo Clinic, Rochester, MN, USA. Clinical Significance for Quality of Life Endpoints in Clinical Trials. FDA/Industry Statistics Workshop Washington, September 16, 2005. Primary goal: advance the state of the science to help cancer patient QOL soar.

359 views • 33 slides

NEJM journal discussion

NEJM journal discussion. Dr. J.A. Coetser Dr. J-M Nel 24 February 2011. Activation of mineralocorticoid receptors by aldosterone and corticosteroids have negative effects on the failing heart.

759 views • 30 slides

Article Critique

Article Critique. Presented by: Confidential Group Members and Kaitlin Deason. Niacin and Statins in Patients with Dyslipidemia.

503 views • 30 slides

Diagnosis Related Groups and AR-DRGs - Introduction

742 views • 26 slides

Diagnosis Related Groups and AR-DRGs - Introduction

295 views • 26 slides

Assessment of Reliable Change: Methods and Assumptions

581 views • 23 slides

Biosimilars 2009 Update Pending Legislation Review

Biosimilars 2009 Update Pending Legislation Review. Pam Politis AIPLA Spring Meeting 2009 May 14, 2009. Follow-on Biologics Bills in the House of Representatives 2009. H.R. 1427 Waxman Bill. H.R. 1545 Eshoo Bill. Pathway for Biosimilars Act Introduced March 17, 2009

233 views • 10 slides

Data-Driven Medical Practice

Data-Driven Medical Practice. Data-Driven Medical Practice. What are the needs? Patients health status health risks progress during treatment Physicians treatment decision support trends in disease management financial management Payers (commercial and government)

147 views • 5 slides